FDA inspection
Larkin Community Hospital IRB: FDA inspection ending May 21, 2025
FDA inspection 1270361 · South Miami, FL
Key facts
| Inspection ID | 1270361 |
|---|---|
| Firm | Larkin Community Hospital IRB |
| FEI number | 1000113240 |
| Address | 7000 Sw 62nd Ave Ste 601 |
| City | South Miami |
| State | FL |
| ZIP | 33143-4716 |
| Fiscal year | 2025 |
| Inspection end date | May 21, 2025 |
| Project area | Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices|Blood and Blood Products|Product Evaluation: Medical Devices |
| Product type | Biologics, Devices, Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data